Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Depreciation & Amortization - Total (2011 - 2013)

Updated

Bioxytran's Depreciation & Amortization - Total was $12,764 in Q2 2013, up 25.8% from $10,145 a year earlier and up 25.3% from the prior quarter.

Analysis

Bioxytran (BIXT) Depreciation & Amortization - Total (2011 - 2013) Analysis & Trends

On a trailing twelve-month basis, Bioxytran's Depreciation & Amortization - Total was $39,676 through Jun 30, 2013.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bioxytran 2.29 Mn 1.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 12,764.00
Mar 31, 2013 10,183.00
Jun 30, 2012 10,145.00
Jun 30, 2011 6,584.00
API Access

Bioxytran Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=BIXT&period=max&api_key=YOUR_API_KEY